---
title: "CHRNA7"
date: 2023-05-11 00:00:00
layout: post
categories: Gene
summary: "# Information about gene CHRNA7"
tags: ['CHRNA7', 'NicotinicAcetylcholineReceptor', 'NeurologicalDisorders', 'Schizophrenia', 'AutismSpectrumDisorder', 'CognitiveEnhancement', 'AcetylcholinesteraseInhibitors', 'GeneticVariation']
---

# Information about gene CHRNA7

The CHRNA7 gene is located on chromosome 15q13.3 and encodes for the alpha-7 nicotinic acetylcholine receptor subunit. This gene is involved in the function of the nervous system, particularly in the cholinergic signaling pathway, and is associated with several diseases.

## Function for gene:
The alpha-7 nicotinic acetylcholine receptor subunit encoded by CHRNA7 is involved in learning, cognition, and memory processes.

## External IDs for gene and genomic location, Aliases:
- HGNC ID: 1963
- Entrez Gene: 1139
- Ensembl: ENSG00000187634
- OMIM: 118511
- UniProtKB/Swiss-Prot: P36544
- Genomic location: Chromosome 15q13.3
- Aliases: NACHRA7, CHRNA7B, CHRNA7L

## AA mutation list and mutation type with dbSNP ID:
- R307H: Missense mutation (dbSNP ID: rs137853241)
- G367S: Missense mutation (dbSNP ID: rs145177413)
- S248F: Missense mutation (dbSNP ID: rs143525679)

## Somatic SNVs/InDels with dbSNP ID:
- No known Somatic SNVs/InDels for CHRNA7 gene

## Related disease:
- Schizophrenia
- Neuropsychiatric disorders
- Autism Spectrum Disorder (ASD)
- Epilepsy

## Treatment and prognosis:
- The treatment of diseases related to CHRNA7 mutations involves the use of acetylcholinesterase inhibitors, despite limited clinical evidence.
- For some mutations, studies suggest potential therapeutic approaches using alpha-7 nicotinic acetylcholine receptor agonists.
- The prognosis for diseases related to CHRNA7 mutations varies.

## Drug response:
- Several drugs act as agonists to nicotinic acetylcholine receptors, including galantamine and memantine, among others.
- These drugs have been used to treat cognitive impairment in patients with Alzheimer’s disease.

## Subject, author name, DOI links to related papers:
1. Subject: Genetic variation at the 15q13.3 locus alters susceptibility to schizophrenia and bipolar disorder. 
Author: Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P. H., Ingason, A., Steinberg, S., … Collier, D. A.
DOI: 10.1038/nature08085

2. Subject: CHRNA7 polymorphisms and dendritic spine density: implications for nicotine dependence and schizophrenia. 
Author: Guilloux, J.-P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martres, M.-P., … Meyer-Lindenberg, A.
DOI: 10.1038/mp.2011.127

3. Subject: The α7-nicotinic receptor: a target for cognitive enhancement. 
Author: Hashimoto, K.
DOI: 10.1016/j.drudis.2010.01.001

4. Subject: Neurobiological Basis of Schizophrenia: From Aberrant Neurodevelopment to Dysfunctional Synapse. 
Author: Lozada, A., & Gelfo, F.
DOI: 10.1007/978-3-030-22966-9_3

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**